GAVI signs COVID-19 vaccine supply deals with Sinovac, Sinopharm for COVAX
GENEVA, July 12 (Reuters) - The GAVI alliance said on Monday it had signed two advance purchase agreements with Chinese drugmakers Sinopharm and Sinovac to provide COVID-19 vaccines to the COVAX programme immediately.
"The agreements, which come at a time when the Delta variant is posing a rising risk to health systems, will begin to make 110 million doses immediately available to participants of the COVAX Facility, with options for additional doses," GAVI said in a statement. (Reporting by Emma Farge, editing by Louise Heavens)
